Revenue grew 24.3% year-over-year to RMB11.7 billion, led by the pig segment, while profit before biological assets fair value adjustments surged 250.6%. Gross margin improved to 17.4%, and the company maintained strong liquidity and continued investments in technology and farmer empowerment.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.